Industry News
Pharmaceutical Industry News
GSK is taking to the airwaves to…
GSK is taking to the airwaves to get the message out about respiratory syncytial virus, presenting a TV special about how the pathogen has affected athletes in the upcoming National Senior Games.
In this episode of “The Top Line,”…
In this episode of "The Top Line," we dive into China’s rapid rise in drug discovery and how global pharma is tapping into the country’s booming R&D pipeline.
Although Sarepta Therapeutics…
Although Sarepta Therapeutics managed to defuse a brief stalemate with the FDA earlier this week, the U.S. drug regulator is reportedly going to put the company to work in order to affirm the safety of
A soon-to-be-released documentary…
A soon-to-be-released documentary aims to change the conversation around hemophilia, where many female patients go misdiagnosed for years and often feel ignored or overlooked by healthcare providers.
A direct-to-consumer program for…
A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.
Just as new outbreaks of…
Just as new outbreaks of chikungunya threaten to become another epidemic, Bavarian Nordic, maker of a vaccine against the mosquito-borne virus, has entered discussions of a potential buyout.
With tariffs looming and pricing…
With tariffs looming and pricing policies shifting, life sciences companies may be on the cusp of a “pivotal moment,” according to Deloitte.
A federal district court in…
A federal district court in Delaware has taken the side of Mylan—now part of Viatris—in a patent litigation case over a proposed generic to Novo Nordisk's obesity blockbuster Wegovy. The court disputed Novo’s argument that
Device CDMO and healthcare…
Device CDMO and healthcare packaging pro Sanner is expanding its global presence with the opening of a new manufacturing facility in Greensboro, North Carolina.
Despite chronic hand eczema…
Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no specific treatment for the condition in the U.S. until the FDA signed off on Leo Pharma’s Anzupgo on Wednesday afternoon.
U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS
PEPFAR, the campaign to end H.I.V. globally, would morph into an effort to detect disease outbreaks and sell American products, according to documents obtained by The Times.
A Pill for Sleep Apnea Could Be on the Horizon
Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition.
During a recent press tour…
During a recent press tour attended by Fierce Pharma, the importance of a homegrown biomanufacturing workforce to the North Carolina's swiftly growing life sciences industry was stressed repeatedly across universities, economic development centers and the
HHS Secretary Robert F. Kennedy…
HHS Secretary Robert F. Kennedy Jr. has signed off on a recommendation from an advisory committee to remove the preservative thimerosal from all flu shots distributed in the United States.
The FDA was set to decide on GSK’s…
The FDA was set to decide on GSK's proposed Blenrep combinations in multiple myeloma by July 23. Instead, the agency is now extending its review through October 23.
Ahead of the 10-year anniversary…
Ahead of the 10-year anniversary of Tagrisso’s original FDA approval this fall, AstraZeneca has debuted the first direct-to-consumer commercial for the lung cancer med.
Roche is pausing shipments of…
Roche is pausing shipments of Elevidys in some countries, following partner Sarepta Therapeutics’ move in the U.S., as safety concerns mount over the Duchenne muscular dystrophy gene therapy.
Genentech has executed another…
Genentech has executed another round of layoffs, eliminating 87 positions at its headquarters in South San Francisco. It is the fourth wave of job cuts from the Roche subsidiary in the last 15 months.
Operating under a new CEO and…
Operating under a new CEO and implementing a fresh turnaround strategy, Swiss CDMO Lonza appears to have closed the chapter on its sales stagnation. Meanwhile, Korea's Samsung Biologics has carried its sales growth streak through
Taiwanese drugmaker Orient Pharma…
Taiwanese drugmaker Orient Pharma has recalled 57,504 bottles of the cholesterol drug pitavastatin. Separately, Tennessee’s AvKARE recalled more than 10,000 bottles of the same drug. Both product pulls were attributed to failed impurity and degradation